Buy Rating Affirmed for Bionomics' BNC210 Following Promising PTSD Study Results
TipRanksMar 28 00:45
Bionomics's BNC210 Shows Promise for PTSD Treatment: A Buy Rating Analysis
TipRanksMar 22 00:05
Bionomics Analyst Ratings
BenzingaMar 22 00:01
HC Wainwright & Co. Reiterates Buy on Bionomics, Maintains $8 Price Target
BenzingaDec 7, 2023 19:38
Bionomics Analyst Ratings
BenzingaDec 7, 2023 19:37
Promising Progress of BNC210 Bolsters Buy Rating on Bionomics Amidst Rising Interest in SAD Treatments
TipRanksOct 3, 2023 18:17
Positive Phase 2b Study Results Bolster Buy Rating for Bionomics' PTSD Drug BNC210
TipRanksSep 29, 2023 00:45
Maxim Group Maintains Buy on Bionomics, Raises Price Target to $10
BenzingaSep 29, 2023 00:43
HC Wainwright & Co. Upgrades Bionomics to Buy, Announces $8 Price Target
BenzingaSep 29, 2023 00:33
Bionomics Analyst Ratings
BenzingaSep 29, 2023 00:28
Analysts Have Conflicting Sentiments on These Healthcare Companies: Travere Therapeutics (TVTX) and Bionomics (BNOX)
TipRanksAug 8, 2023 00:10
Maxim Group Initiates Coverage On Bionomics With Buy Rating, Announces Price Target of $7
BenzingaJun 16, 2023 21:57
H.C. Wainwright Keeps Their Hold Rating on Bionomics (BNOX)
TipRanksMar 10, 2023 01:17
Loops Capital Adjusts Price Target on Bionomics to $17 From $10, Keeps Buy Rating
MT NewswiresMar 9, 2023 23:31
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
Benzinga Real-time NewsDec 20, 2022 21:06
Bionomics Analyst Ratings
Benzinga Analyst RatingsDec 20, 2022 18:11
Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6
Benzinga Real-time NewsDec 20, 2022 18:11
Bionomics Analyst Ratings
Benzinga Analyst RatingsDec 19, 2022 19:16
No Data
No Data